140
Participants
Start Date
September 10, 2024
Primary Completion Date
December 25, 2024
Study Completion Date
March 10, 2025
Gyntima Menopause
Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021
Placebo
Placebo comparator
Kaneka Americas Holding Inc.
INDUSTRY
Community Pharmacology Services Ltd
OTHER